THE GROUP .
Working on biocompatible nanoparticle systems for use as MRI contrast agents.
Working on paramagnetic inorganic-organic hybrid nanoparticle imaging systems.
Working on paramagnetic bioresponsive nanoparticles as MRI contrast agents.
Working on electrochemical microfluidics and kinetics quantification in diagnostics.
Investigating metabolic plasticity in prostate cancer bone metastases and novel circulating tumour cell (CTC) isolation methodology. More specifically, developing nanoparticle and microfluidic-based approaches for detection and isolation of prostate cancer CTCs.
Working on nanoparticle capture systems and parkinsons diagnostics.
Working on electrochemical microfluidics and parkinsons diagnostics.
Trying not to chase wild animals while covering the world in my fluff.
Designing nanoparticles for applications in medical diagnostics. Specifically, as biomarker isolation agents in Parkinson’s diagnostics, or as MRI contrast agents.
Working on nanoparticle-based diagnostics and electrochemical microfluidics
Engineering ionic and molecular transport across membranes
FORMER MEMBERS IN ACADEMIA .
Multiple previous members of the group are now in academic positions around the world, including:
- Dr Robert Hein (University of Muenster)
- Dr Abdul Ismail (University of Paris-Saclay)
- Dr Jan Tkac (Slovak Academy of Sciences, Slovakia)
- Dr Xiliang Luo (Qingdao University of Science and Technology)
- Dr Joshua Lehr (University of Salford)
- Dr Gemma Louise-Davies (University of Birmingham)
- Dr Mohamed Sharafeldin (University of Otago, New Zealand)
